EPO and retinopathy of prematurity: The PENUT study failed to show effects of early administration of exogenous EPO in premature infants born less than 28 weeks gestation on ROP or on neurocognitive milestones at age 2, which was different from a meta-analysis of four randomized studies that found EPO reduced the risk neurocognitive dysfunction.